MyFinsight
Home
About
Contact
spry: the income statement
Download
Download image
Comprehensive loss
-$51,112K
(-174.15%↓ Y/Y)
Change in unrealized
gains and losses on...
$39K
(-91.94%↓ Y/Y)
Net loss
-$51,151K
(-167.41%↓ Y/Y)
Other income
(expense), net (including...
$2,041K
(-22.10%↓ Y/Y)
Revenue Under Supply
Agreements
$1,146K
Revenue Under
Collaboration Agreements
$55K
Product
$31,300K
Loss from operations
-$53,192K
(-144.58%↓ Y/Y)
Total revenue
$32,501K
(1471.62%↑ Y/Y)
Total operating
expenses
$85,693K
(259.81%↑ Y/Y)
Selling, general and
administrative (including...
$74,751K
(287.69%↑ Y/Y)
Research and development
(including related party...
$2,751K
(-37.80%↓ Y/Y)
Cost of goods sold
(including related party...
$8,191K
(7213.39%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)